Derek N. Adams's Insider Trades & SAST Disclosures

Derek N. Adams's most recent trade in Kalaris Therapeutics Inc. was a trade of 35,000 Common Stock done . Disclosure was reported to the exchange on June 6, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kalaris Therapeutics Inc.
Derek N. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 35,000 70,000 - 0 Common Stock
Kalaris Therapeutics Inc.
Derek N. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 35,000 35,000 - 0 Common Stock
Kalaris Therapeutics Inc.
Derek N. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 45,000 45,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades